THX Pharma (FRA:3VG) Buyback Yield %: -14.53 (As of Jun. 25, 2026)


FRA:3VG THX Pharma FRA:3VG
30 GF Score
Price €3.22
! 1 Warning Sign
View Full Analysis

What is THX Pharma Buyback Yield %?

THX Pharma FRA:3VG +1.10% 30 Buyback Yield % is -14.53 as of Jun. 25, 2026. GuruFocus rates FRA:3VG with a GF Score™ of 30/100. The stock has 1 warning sign investors should review. Among 745 Biotechnology companies, THX Pharma ranks worse than 59.87% on this metric.

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

THX Pharma's current buyback yield was -14.53%.

THX Pharma Buyback Yield % Historical Data

* Premium members only.

The historical data trend for THX Pharma's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

THX Pharma Buyback Yield % Chart

THX Pharma Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Buyback Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -35.40 -7.72 -35.97 -7.41 -26.22

THX Pharma Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -33.47 0.00 -6.86 -3.83 -24.51

FRA:3VG vs VRTX, REGN, ALNY: Buyback Yield % Comparison

For the Biotechnology subindustry, THX Pharma's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

THX Pharma Buyback Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, THX Pharma's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where THX Pharma's Buyback Yield % falls into.


FRA:3VG
30GF Score
THX Pharma FRA:3VG
Buyback Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

THX Pharma Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

THX Pharma's Buyback Yield for the fiscal year that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 7.219) / 27.53
=-26.22%

THX Pharma's annualized Buyback Yield for the quarter that ended in Dec. 2025 is calculated as

Buyback Yield=Net Issuance of Stock(TTM) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) (TTM)** / Market Cap
=- (0 + 7.219) / 27.53
=-26.22%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** If the quarter corresponds to the year-end period, we will use the annual Repurchase of Stock and Issuance of Stock data .

Frequently Asked Questions Learn more about Buyback Yield % →
What does a Buyback Yield % of -14.53 mean?
THX Pharma (FRA:3VG) has a Buyback Yield % of -14.53 as of Jun. 25, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on THX Pharma and its competitors. According to the industry distribution chart, THX Pharma ranks #446 out of 745 companies in the Biotechnology industry, placing it in the top 59.9%.
Is THX Pharma's Buyback Yield % too high?
THX Pharma's current Buyback Yield % is -14.53. Based on the distribution chart, THX Pharma ranks #446 out of 745 companies in the Biotechnology industry, which is below the industry midpoint. Overall, THX Pharma has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does THX Pharma's Buyback Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, THX Pharma ranks #446 out of 745 companies for Buyback Yield %. This places THX Pharma in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Biotechnology company?
A good Buyback Yield % depends on the Biotechnology industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on THX Pharma and its competitors. THX Pharma's current Buyback Yield % is -14.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is THX Pharma stock overvalued right now?
THX Pharma (FRA:3VG) has a current Buyback Yield % of -14.53. The current Buyback Yield % is -14.53. THX Pharma's overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For THX Pharma (FRA:3VG), the current Buyback Yield % is -14.53 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

THX Pharma Business Description

Other Exchanges ALTHX:France3VG:Germany
Address 60 avenue Rockefeller, Pepiniere Laennec, Lyon, FRA, 69008
THX Pharma Formerly Theranexus SA is a France based biopharmaceutical company. It is engaged in developing drug candidates to be used in the treatment of central nervous system (CNS) disorders. The company's therapeutics platform is based on simultaneously targeting neurons and glial cells by creating and developing innovative combinations of two distinct drugs: a CNS drug targeting neuronal activity; and a drug targeting glial cells. The drug candidates of the organization are THN102 to treat excessive daytime sleepiness in Parkinson's disease, THN201 for the treatment of neurocognitive disorders in Alzheimer's disease and THN101 for neuropathic pain.
30GF Score

Get the complete analysis for FRA:3VG

Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.22
Price